Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

588
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
588
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

675
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
675
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

358
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
358
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

374
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
374
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

402
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
402
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.

Nature genetics·2025
Same author

Bidirectional analysis of the association between migraine and post-traumatic stress disorder in Nurses' Health Study II.

Epidemiology and psychiatric sciences·2024
Same author

Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2024
Same author

Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.

medRxiv : the preprint server for health sciences·2024
Same author

Author Correction: Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.

Nature communications·2022
Same author

Long-Term Aspirin Use and Self-Reported Walking Speed in Older Men: The Physicians' Health Study.

The Journal of frailty & aging·2022

関連する実験動画

Updated: May 5, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

13.2K

男性における鎮痛剤の使用と腎機能

K M Rexrode1, J E Buring, R J Glynn

  • 1Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave, Boston, MA 02215, USA. gaziano@maveric.org

JAMA
|July 24, 2001
PubMed
まとめ
この要約は機械生成です。

アセトアミノフェンやアスピリンなどの一般的な鎮痛剤の適度な使用は,健康な男性における腎臓疾患のリスクの増加と関連していない. この大規模な研究では,鎮痛薬の使用と腎臓機能不全との間に有意な関連性が見つかりませんでした.

さらに関連する動画

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K

関連する実験動画

Last Updated: May 5, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

13.2K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K

科学分野:

  • ネフロロジーは腎臓科
  • エピデミオロジー エピデミオロジー
  • 薬理学 薬理学とは

背景:

  • 症例対照研究では,鎮痛剤の使用と慢性腎臓病との関連が示唆されています.
  • しかし,この関連性を調査する堅実なコホート研究は限られている.

研究 の 目的:

  • 鎮痛剤の摂取と腎臓機能障害を発症するリスクとの関連を調査する.
  • この研究は,一般的な鎮痛剤が腎臓の健康に与える影響を明らかにすることを目的とした.

主な方法:

  • Physicians' Health Study (医師の健康調査) の最初は健康な男性11,032人を対象とした14年間のコホート研究.
  • 鎮痛剤 (アセトアミノフェン,アスピリン,NSAID) の使用は自己報告され,クレアチニンの上昇またはクレアチニンのクリアランスの低下によって定義される腎機能不全がありました.
  • 様々な健康とライフスタイル要因に調整された多変量分析.

主要な成果:

  • アセトアミノフェン,アスピリン,または他の非ステロイド性抗炎症薬 (NSAIDs) の使用とクレアチニン濃度の上昇との間に有意な関連性が見つかりませんでした.
  • 同様に,クレアチニンクリアランスの低下は,鎮痛剤の使用と有意な関連性を示さなかった.
  • 鎮痛剤の累積摂取量が高くても,腎臓機能不全のリスクの増加と相関関係はありませんでした.

結論:

  • アセトアミノフェン,アスピリン,およびNSAIDを含む一般的な鎮痛剤の適度な使用は,当初健康な男性において腎機能不全のリスクを増加させるようには見えません.
  • 発見は,典型的な鎮痛剤の消費が,この集団における腎臓機能に安全である可能性があることを示唆しています.